Quantcast

Latest Autoantibody Stories

2009-01-21 16:13:21

Mice from a strain that ordinarily develops systemic lupus erythematosus (SLE), but bred with a deficiency in receptor for the protein Interleukin 21, stayed healthy and exhibited none of the symptoms of the disease, researchers at The Jackson Laboratory and National Institutes of Health report. SLE is an autoimmune disease, with symptoms of varying severity including include painful or swollen joints, unexplained fever and extreme fatigue. An estimated 2 million Americans --nine out of 10 of...

2009-01-13 01:00:00

LONDON, Jan. 13 /PRNewswire/ -- Based on its recent analysis of the autoimmune disease diagnostics markets, Frost & Sullivan recognizes Toscana Biomarkers with the 2008 European Frost & Sullivan Excellence in Research Award. The company demonstrated that the incorporation of synthetically modified peptides for the validation and discovery of biomarkers aids effective diagnosis of autoimmune diseases and is also looking to adopt robust methods to identify novel diagnostic solutions....

2008-12-23 14:44:24

Implications for new tests and more personalized treatments for autoimmune diseases More drafts usually mean a better product and so it also seems to go with the human immune system. As B cells develop, genes rearrange to allow their antibodies to recognize different foreign invaders or pathogens. But sometimes antibodies are created that recognize and attack the body's own cells. These self-reactive antibodies, like early drafts of a manuscript, must be edited into safer versions. This...

1c1cc506955e6c931ab23c9cbe1628f41
2008-10-24 11:40:00

A powerful antioxidant in green tea may prevent or delay the onset of type 1 diabetes, Medical College of Georgia researchers say. Researchers were testing EGCG, green tea's predominant antioxidant, in a laboratory mouse with type 1 diabetes and primary Sjogren's syndrome, which damages moisture-producing glands, causing dry mouth and eyes. "Our study focused on Sjogren's syndrome, so learning that EGCG also can prevent and delay insulin-dependent type 1 diabetes was a big surprise," says Dr....

2008-09-03 06:00:06

ZymoGenetics, Inc. (NASDAQ: ZGEN) today announced a restructuring of its partnership with Merck Serono, a division of Merck KGaA, Darmstadt, Germany. With respect to the ongoing development of atacicept, ZymoGenetics exercised its contractual right to convert to a worldwide royalty license. By making this election, ZymoGenetics will no longer be responsible for funding development costs, and Merck Serono will fund 100% of the program costs on a worldwide basis. Merck Serono will now have...

2008-08-27 09:00:23

ROCKVILLE, Md., Aug. 27 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. today announced it has completed enrollment and initial dosing in BLISS-76, the second of two pivotal Phase 3 randomized clinical trials of LymphoStat-B(R) (belimumab) in patients with active systemic lupus erythematosus (SLE). Belimumab is being developed by HGS and GlaxoSmithKline (GSK) under a co-development and commercialization agreement entered into in August 2006. (Logo:...

2008-07-28 12:00:23

To: NATIONAL EDITORS Contact: Michele Kling of March of Dimes, +1-914-997-4613 Team Supported by March of Dimes Publishes Findings in Nature Medicine WHITE PLAINS, N.Y.,July 28/PRNewswire-USNewswire/ -- In a new March of Dimes-funded study of pre-eclampsia, a serious and potentially deadly disorder that affects about 5 percent of pregnancies, researchers have found results in mice that may have important implications for diagnosis and treatment in humans. Yang Xia, M.D., Ph.D., and...

2008-07-21 08:45:08

Hadasit Bio-Holdings, (HBL) a subsidiary of Hadasit (the technology transfer company of the Hadassah - Hebrew University Medical Center), which is traded on the Tel Aviv Stock Exchange under the symbol HDST, announced today that one of its portfolio companies, Verto (in which it has a 75% stake), has successfully completed a human clinical trial of a device for treating patients who suffer from systemic lupus erythematosus. The goals of the trial at the Hadassah Medical Center in Ein...

2008-07-17 03:00:38

MARTINSRIED, Germany, July 17, 2008 (PRIME NEWSWIRE) -- MorphoSys AG (FSE:MOR) (Prime Standard Segment, TecDAX) announced today that Phadia AB, a world leader in autoimmunity and allergy testing, has implemented a series of HuCAL-based recombinant antibodies in its marketed autoimmune tests Varelisa(tm) and EliA(tm). Thereby Phadia becomes the first diagnostic company to introduce recombinant antibodies in an autoimmune screening platform. AbD Serotec, MorphoSys's division for research and...

2008-06-26 06:02:00

By Lee, Jeffery CLINICAL REVIEW Section 1 Epidemiology and aetiology Sjogren's syndrome (SS) is arelatively underdiagnosed cause for dry eyes (xerophthalmia) and mouth (xerostomia), and the diagnosis is often delayed for months to years. The presence of xerostomia and xerophthalmia is also called sicca syndrome. It is considered one of the commonest autoimmune connective tissue disorders, with a prevalence of 0.5-3 per cent in the adult population and is similar in most racial groups...


Word of the Day
toccata
  • In music, a work for a keyboard-instrument, like the pianoforte or organ, originally intended to utilize and display varieties of touch: but the term has been extended so as to include many irregular works, similar to the prelude, the fantasia, and the improvisation.
This word is Italian in origin, coming from the feminine past participle of 'toccare,' to touch.
Related